Cytomegalovirus
Home » Specialties » Transplant Infections » Cytomegalovirus
What Is Cytomegalovirus (CMV)?
How SSRC Helps You
- Early detection using advanced viral load monitoring (CMV PCR).
- Tailored antiviral treatment based on your transplant type and overall health.
- Close coordination with your transplant surgeon and immunosuppression team.
- Continuous follow-up, preventing complications such as organ rejection or tissue damage.
With SSRC’s expertise, CMV becomes a manageable, controlled part of post-transplant care — not a crisis.
Who Is at Risk?
Symptoms of CMV
- Fever and persistent fatigue
- Loss of appetite
- Low white blood cell counts
- Abdominal discomfort or diarrhea
- Shortness of breath (lung involvement)
- Visual changes (rare but serious)
- Organ-specific inflammation
How CMV Is Diagnosed at SSRC
- CMV PCR viral load testing
- CMV antigen detection
- Organ imaging when needed
- Blood count evaluation
- Endoscopic evaluation (if the gastrointestinal tract is affected)
Early CMV Care for Safe Transplant Recovery
CMV can reactivate in weakened immune states. SSRC specialists step in early to protect your organ and your health.
Treatment Options
- Antiviral medications such as valganciclovir or ganciclovir
- Adjustments in immunosuppressive therapy
- IV antiviral therapy for severe cases
- Supportive care to manage organ-specific symptoms
Why Choose SSRC?
SSRC brings a highly specialized, coordinated, and evidence-based approach to transplant infections. With experts like Dr. Gopika Mohan, Dr. Alka Sirohi, and a dedicated clinical team, SSRC ensures comprehensive monitoring and rapid response — safeguarding both your recovery and your transplanted organ. Every plan is individualized, keeping your safety and long-term health at the center.
Frequently Asked Questions (FAQs)
Yes. CMV can affect the transplanted organ and cause serious complications if untreated, which is why regular monitoring is essential.
Typically weekly during the early months, then less frequently as your recovery stabilizes — depending on your transplant team’s plan.
It can, especially in patients requiring strong immunosuppressive medications. SSRC provides long-term monitoring to prevent recurrence.
Fatigue, fever, abdominal discomfort, and low blood counts. In some cases, symptoms may be minimal — making regular testing important.
Yes. CMV can cause inflammation in the transplanted organ if not controlled, but early treatment at SSRC significantly reduces this risk.
High-risk patients usually receive prophylaxis, while others are monitored closely. SSRC customises this based on donor-recipient CMV status.